Litcius/Paper detail

SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities

Yonglan Liu, Wengang Zhang, Hyunbum Jang, Ruth Nussinov

2023Cellular and Molecular Life Sciences25 citationsDOIOpen Access PDF

Topics & Concepts

Noonan syndromeMutationCancerPhenotypeGeneticsPTPN11MutantBiologyCancer researchCostello syndromeGeneKRASProtein Tyrosine PhosphatasesATP Synthase and ATPases ResearchGalectins and Cancer Biology
SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities | Litcius